Artículos por temáticas

New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease

Wu JJ, Yang Y, Wan Y, Xia J, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C.

Biomed Pharmacother. 2022 Aug;152:113207. doi: 10.1016/j.biopha.2022.113207. Epub 2022 Jun 3.

Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review

Miao Y, Cui L, Li J, Chen Y, Xie X, Guo Q.

J Alzheimers Dis. 2022;89(4):1131-1142. doi: 10.3233/JAD-220374.

Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors

George G, Koyiparambath VP, Sukumaran S, Nair AS, Pappachan LK, Al-Sehemi AG, Kim H, Mathew B.

Int J Mol Sci. 2022 Mar 14;23(6):3121. doi: 10.3390/ijms23063121.

Current Research on Pro-drug Therapies for Parkinson's and Alzheimer's Disease

Huo C, Wu L, Jiang Z, Yang J, Wang Z, Li Y, Qian S.

Med Chem. 2022;18(6):655-666. doi: 10.2174/1573406418666211130150821.

Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease

Sivaraman B, Raji V, Velmurugan BA, Natarajan R.

CNS Neurol Disord Drug Targets. 2022;21(5):427-449. doi: 10.2174/1871527320666210928160159.

PET Imaging in Preclinical Anti-Aβ Drug Development

Syvänen S, Meier SR, Roshanbin S, Xiong M, Faresjö R, Gustavsson T, Bonvicini G, Schlein E, Aguilar X, Julku U, Eriksson J, Sehlin D.

Pharm Res. 2022 Jul;39(7):1481-1496. doi: 10.1007/s11095-022-03277-z. Epub 2022 May 2.

Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease

Kumari S, Singh A, Singh AK, Yadav Y, Bajpai S, Kumar P, Upadhyay AD, Shekhar S, Dwivedi S, Dey AB, Dey S.

J Alzheimers Dis. 2022;85(1):249-260. doi: 10.3233/JAD-215347.

Alzheimer's disease genes and proteins associated with resistance and aerobic training: An in silico analysis

Coutinho LA, Leão LL, Cassilhas RC, de Paula AMB, Deslandes AC, Monteiro-Junior RS.

Exp Gerontol. 2022 Oct 15;168:111948. doi: 10.1016/j.exger.2022.111948. Epub 2022 Sep 7.

Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease

Li X, Li W, Tian P, Tan T.

Biotechnol Adv. 2022 Nov;60:108026. doi: 10.1016/j.biotechadv.2022.108026. Epub 2022 Jul 30.

Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation

Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.

Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.

Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease

Shi Y, Bao Q, Chen W, Wang L, Peng D, Liu J, Liu Q, Zhang Y, Ji Z, Shen A.

J Alzheimers Dis. 2022;87(1):1-15. doi: 10.3233/JAD-215666.

Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models

Jin N, Babiloni C, Drinkenburg WH, Hajós M, Nygaard HB, Tanila H.

J Alzheimers Dis. 2022;88(3):849-865. doi: 10.3233/JAD-210209.

Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids

Barak M, Fedorova V, Pospisilova V, Raska J, Vochyanova S, Sedmik J, Hribkova H, Klimova H, Vanova T, Bohaciakova D.

Stem Cell Rev Rep. 2022 Feb;18(2):792-820. doi: 10.1007/s12015-021-10254-3. Epub 2022 Feb 2.

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil

Tariot PN, Braeckman R, Oh C.

J Alzheimers Dis. 2022;90(1):161-172. doi: 10.3233/JAD-220530.

Medicine-Food Herbs against Alzheimer's Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action

Guo P, Zhang B, Zhao J, Wang C, Wang Z, Liu A, Du G.

Molecules. 2022 Jan 28;27(3):901. doi: 10.3390/molecules27030901.